Different treatment response to systemic corticosteroids according to white blood cell counts in severe COVID-19 patients.

Kwang Yong ChoiDong Hyun KimKwang Nam JinHyo Jin LeeTae Yun ParkBorim RyuJung-Kyu LeeEun Young HeoDeog Kyeom KimHyun Woo Lee

Published in: Annals of medicine (2022)

Leukopoenia may be related with a better response to systemic corticosteroid therapy in COVID-19 patients requiring oxygen supplementation.KEY MESSAGESIn severe COVID-19 treated with systemic corticosteroids, patients with leukopoenia showed a lower hazard for composite poor outcome compared to patients with normal white blood cell counts or leukocytosis.Leukopoenia may be a potential biomarker for better response to systemic corticosteroid therapy in COVID-19 pneumonia.

Keyphrases

sars cov
coronavirus disease
cell therapy
single cell
drug induced
early onset
bone marrow
mechanical ventilation